AwardTape · Defense awards · Medical · Drugs and biologicals · HT941023P2071
HT941023P2071: $204K purchase order to RLS (usa) Inc
RLS (usa) Inc holds a purchase order from Defense Health Agency with $204K obligated since Oct 2023, against a ceiling of $204K. Latest action Jan 8, 2026.
Radiopharmaceutical
| PIID | HT941023P2071 |
|---|---|
| Type | purchase order |
| Company | RLS (usa) Inc |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY HCD WEST |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325412 PHARMACEUTICAL PREPARATION MANUFACTURING |
| Obligated since Oct 2023 | $204K |
| Total obligated (lifetime) | $204K |
| Ceiling (base and all options) | $204K |
| Base date | Oct 1, 2023 |
| Latest action | Jan 8, 2026 |
| End date | Sep 30, 2026 |
| Actions since Oct 2023 | 6 |
| Pricing | Firm fixed price |
| Competition | Competed under simplified acquisition |
| Place of performance | IL |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial